Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Lintzeris

Showing results (41-50 of 213) with videos related to

Pageof 22
Sort By:
Drug and Alcohol Review|June 9, 2016
Opioid agonist doses for oxycodone and morphine dependence: Findings from a retrospective case seriesSuzanne Nielsen, Raimondo Bruno, Louisa Degenhardt, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|February 17, 2012
Unplanned pregnancy and contraceptive use in women attending drug treatment servicesKirsten I Black, Christine Stephens, Paul S Haber, et al.
Internal Medicine Journal|August 7, 2019
Estimating Centre for Disease Control and Prevention-defined overdose risk in people prescribed opioids for chronic non-cancer pain: implications for take-home naloxone provisionNicholas Lintzeris, Thomas Santo, Suzanne Nielsen, et al.
Journal of Clinical Psychopharmacology|May 17, 2006
Interactions on mixing diazepam with methadone or buprenorphine in maintenance patientsNicholas Lintzeris, Timothy B Mitchell, Alyson Bond, et al.
Drug and Alcohol Review|April 25, 2023
The DACRIN data project: A process for harmonising data collection for clinical research in alcohol and other drugs services in New South WalesLauren A Monds, Libby Topp, Jade Pados, et al.
Addiction (Abingdon, England)|November 2, 2002
A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawalNicholas Lintzeris, James Bell, Gabriele Bammer, et al.
Drug and Alcohol Dependence|May 22, 2003
Buprenorphine dosing regime for inpatient heroin withdrawal: a symptom-triggered dose titration studyNicholas Lintzeris, Gabriele Bammer, Louise Rushworth, et al.
The Medical Journal of Australia|April 24, 2008
Unplanned admissions to two Sydney public hospitals after naltrexone implantsNicholas Lintzeris, Soung Lee, Lucinda Scopelliti, et al.
The American Journal on Addictions|June 19, 2004
Implementing buprenorphine treatment in community settings in Australia: experiences from the Buprenorphine Implementation TrialNicholas Lintzeris, Alison Ritter, Mary Panjari, et al.
Drug and Alcohol Dependence|April 26, 2015
The introduction of a potentially abuse deterrent oxycodone formulation: Early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) studyLouisa Degenhardt, Raimondo Bruno, Robert Ali, et al.
Pageof 22

Showing results (41-50 of 213) with videos related to

Sort By:
Pageof 22
Drug and Alcohol Review|June 9, 2016
Opioid agonist doses for oxycodone and morphine dependence: Findings from a retrospective case seriesSuzanne Nielsen, Raimondo Bruno, Louisa Degenhardt, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|February 17, 2012
Unplanned pregnancy and contraceptive use in women attending drug treatment servicesKirsten I Black, Christine Stephens, Paul S Haber, et al.
Internal Medicine Journal|August 7, 2019
Estimating Centre for Disease Control and Prevention-defined overdose risk in people prescribed opioids for chronic non-cancer pain: implications for take-home naloxone provisionNicholas Lintzeris, Thomas Santo, Suzanne Nielsen, et al.
Journal of Clinical Psychopharmacology|May 17, 2006
Interactions on mixing diazepam with methadone or buprenorphine in maintenance patientsNicholas Lintzeris, Timothy B Mitchell, Alyson Bond, et al.
Drug and Alcohol Review|April 25, 2023
The DACRIN data project: A process for harmonising data collection for clinical research in alcohol and other drugs services in New South WalesLauren A Monds, Libby Topp, Jade Pados, et al.
Addiction (Abingdon, England)|November 2, 2002
A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawalNicholas Lintzeris, James Bell, Gabriele Bammer, et al.
Drug and Alcohol Dependence|May 22, 2003
Buprenorphine dosing regime for inpatient heroin withdrawal: a symptom-triggered dose titration studyNicholas Lintzeris, Gabriele Bammer, Louise Rushworth, et al.
The Medical Journal of Australia|April 24, 2008
Unplanned admissions to two Sydney public hospitals after naltrexone implantsNicholas Lintzeris, Soung Lee, Lucinda Scopelliti, et al.
The American Journal on Addictions|June 19, 2004
Implementing buprenorphine treatment in community settings in Australia: experiences from the Buprenorphine Implementation TrialNicholas Lintzeris, Alison Ritter, Mary Panjari, et al.
Drug and Alcohol Dependence|April 26, 2015
The introduction of a potentially abuse deterrent oxycodone formulation: Early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) studyLouisa Degenhardt, Raimondo Bruno, Robert Ali, et al.
Pageof 22